Adults with low vitamin D levels, measured as serum calcidiol below 50 nmol/L, have reduced bone mineralization, which increases the risk of osteomalacia and osteoporosis with higher fracture rates, especially in older individuals, due to decreased intestinal absorption of calcium and phosphorus and altered bone remodeling processes.
See the scientific wording
Vitamin D deficiency, defined as serum calcidiol levels below 50 nmol/L, is associated with impaired bone mineralization, leading to an increased risk of osteomalacia in adults and osteoporosis with higher fracture rates, particularly in older populations, due to reduced intestinal calcium and phosphorus absorption and disrupted skeletal remodeling.
Correlational — new studies may shift this
One low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Narrative ReviewReview
This study says vitamin D helps your body absorb calcium and phosphorus from food, which are needed to keep bones strong. So if you don’t have enough vitamin D, your bones can become weak and break more easily — especially as you get older.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When vitamin D levels are too low, the body cannot absorb enough calcium and phosphorus from food, so blood levels of these minerals drop. The bones cannot harden properly because there is not enough calcium and phosphorus to form mineral crystals in the bone matrix. To compensate, the body breaks down bone tissue to release calcium into the blood, which weakens the bones over time and makes them more likely to break.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Adults with low vitamin D levels, measured as serum calcidiol below 50 nmol/L, have reduced bone mineralization, which increases the risk of osteomalacia and osteoporosis with higher fracture rates, especially in older individuals, due to decreased intestinal absorption of calcium and phosphorus and altered bone remodeling processes.
Mechanism
1 studyWithout enough vitamin D, the body cannot pull calcium and phosphorus from food into the blood. Without those minerals, bones cannot harden properly. To keep blood calcium stable, the body starts breaking down bone, making it soft and weak. Over time, this leads to bones that break easily.
When vitamin D levels are too low, the body cannot absorb enough calcium and phosphorus from food, so blood levels of these minerals drop. The bones cannot harden properly because there is not enough calcium and phosphorus to form mineral crystals in the bone matrix. To compensate, the body breaks down bone tissue to release calcium into the blood, which weakens the bones over time and makes them more likely to break.
Serum calcidiol levels fall below 50 nmol/L, reducing activation of the vitamin D receptor in intestinal epithelial cells
Downregulation of calcium transport proteins TRPV6 and calbindin-D9k and phosphate transporters occurs in the small intestine
Intestinal absorption of calcium decreases from 15–40% to 10% and phosphorus absorption decreases from 80% to 60%
Serum calcium and phosphorus concentrations decline below thresholds required for hydroxyapatite crystal formation
Parathyroid hormone secretion increases in response to low serum calcium
Osteoclast activity is stimulated to resorb bone mineral and release calcium into the bloodstream
Bone matrix remains unmineralized due to insufficient calcium and phosphorus availability, leading to osteomalacia
Chronic bone resorption without adequate mineralization reduces bone density and structural integrity, increasing fracture risk
Evidence from Studies
Supporting (1)
Community contributions welcome
This study says vitamin D helps your body absorb calcium and phosphorus from food, which are needed to keep bones strong. So if you don’t have enough vitamin D, your bones can become weak and break more easily — especially as you get older.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
Clinical support requires direct evidence. Mechanistic proxy and tangential studies contribute only to the mechanistic score.
- All linked studies are tangential or mechanistic proxies — no direct test of the claim has been found.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Serum Calcidiol Levels Below 50 nmol/L and Risk of Osteomalacia and Osteoporotic Fractures in Adults
Population: Adults aged 50+ with measured serum calcidiol levels; Intervention: None (observational); Comparator: Serum calcidiol ≥50 nmol/L; Outcome: Incidence of osteomalacia, osteoporosis diagnosis, and fracture rates; Duration: Minimum 5 years of follow-up.
Double-Blind Placebo-Controlled Trial of Vitamin D Supplementation to Prevent Osteomalacia and Fractures in Adults with Serum Calcidiol <50 nmol/L
Population: Adults aged 50+ with serum calcidiol <50 nmol/L; Intervention: Oral vitamin D3 to raise serum calcidiol to ≥75 nmol/L; Comparator: Placebo; Outcome: Incidence of osteomalacia (confirmed by bone biopsy or imaging), osteoporosis diagnosis, and fracture rates; Duration: Minimum 3 years.
Prospective Cohort Study of Serum Calcidiol Levels and Long-Term Risk of Osteomalacia and Fractures in Middle-Aged and Older Adults
Population: Adults aged 40–75 with baseline serum calcidiol measurement; Intervention: None (observational); Comparator: Groups stratified by serum calcidiol levels (<50, 50–75, >75 nmol/L); Outcome: Incident osteomalacia, osteoporosis, and fractures over 10 years; Duration: 10 years.
Case-Control Study Comparing Serum Calcidiol Levels in Adults with Osteomalacia or Osteoporotic Fractures Versus Age-Matched Controls Without These Conditions
Population: Adults with confirmed osteomalacia or osteoporotic fractures (cases) vs. age-, sex-, and comorbidity-matched adults without these conditions (controls); Intervention: None; Comparator: Serum calcidiol levels at time of diagnosis; Outcome: Prevalence of serum calcidiol <50 nmol/L in cases vs. controls.
In Vitro Study of Vitamin D Deficiency Effects on Osteoblast-Mediated Mineralization and Intestinal Epithelial Calcium/Phosphorus Transport
Population: Human osteoblasts and intestinal epithelial cells in culture; Intervention: Culture media with low (0–10 nmol/L) vs. normal (50–100 nmol/L) calcidiol; Comparator: Normal calcidiol conditions; Outcome: Mineralization rate, gene expression of calcium transporters (TRPV6, CaBP), and phosphate uptake; Duration: 7–21 days.